Clinical Trial Update: Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating capecitabine/oxaliplatin chemotherapy with cemiplimab, with or without fianlimab or REGN7075, in locally advanced rectal cancer an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)
• OXALIPLATIN (Oxaliplatin)
• REGN7075 (REGN7075)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING